Variant report

Variant	nsv1062610
Chromosome Location	chr17:33671466-33758566
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr17:33700735-33700996	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr17:33673564-33673712	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr17:33672911-33673111	H1-hESC	embryonic stem cell:	n/a	n/a
4	BCLAF1	chr17:33700435-33700893	GM12878	blood:	n/a	n/a
5	BHLHE40	chr17:33731448-33731557	GM12878	blood:	n/a	n/a
6	BHLHE40	chr17:33700507-33700933	GM12878	blood:	n/a	n/a
7	BRCA1	chr17:33700927-33700952	Hela-S3	cervix:	n/a	n/a
8	CEBPB	chr17:33717720-33718093	IMR90	lung:	n/a	chr17:33717904-33717917 chr17:33717904-33717917 chr17:33717905-33717916
9	CEBPB	chr17:33673192-33673389	Hela-S3	cervix:	n/a	chr17:33673292-33673303 chr17:33673367-33673378
10	CEBPB	chr17:33717748-33718067	H1-hESC	embryonic stem cell:	n/a	chr17:33717904-33717917 chr17:33717904-33717917 chr17:33717905-33717916
11	CEBPB	chr17:33717739-33718092	Hela-S3	cervix:	n/a	chr17:33717904-33717917 chr17:33717904-33717917 chr17:33717905-33717916
12	CEBPB	chr17:33717633-33718161	A549	lung:	n/a	chr17:33717904-33717917 chr17:33717904-33717917 chr17:33717905-33717916
13	CEBPB	chr17:33717731-33718093	A549	lung:	n/a	chr17:33717904-33717917 chr17:33717904-33717917 chr17:33717905-33717916
14	CEBPB	chr17:33717804-33717994	MCF-7	breast:	n/a	chr17:33717904-33717917 chr17:33717904-33717917 chr17:33717905-33717916
15	CEBPB	chr17:33698406-33698449	H1-hESC	embryonic stem cell:	n/a	n/a
16	CEBPB	chr17:33717723-33718092	HepG2	liver:	n/a	chr17:33717904-33717917 chr17:33717904-33717917 chr17:33717905-33717916
17	CEBPB	chr17:33673203-33673334	HepG2	liver:	n/a	chr17:33673292-33673303
18	CEBPB	chr17:33681579-33681723	IMR90	lung:	n/a	chr17:33681650-33681661
19	CEBPB	chr17:33675103-33675265	A549	lung:	n/a	n/a
20	CEBPB	chr17:33701311-33701959	IMR90	lung:	n/a	n/a
21	CEBPB	chr17:33681594-33681772	HepG2	liver:	n/a	chr17:33681650-33681661
22	CEBPB	chr17:33673119-33673695	H1-hESC	embryonic stem cell:	n/a	chr17:33673292-33673303 chr17:33673367-33673378
23	CEBPB	chr17:33717673-33718118	A549	lung:	n/a	chr17:33717904-33717917 chr17:33717904-33717917 chr17:33717905-33717916
24	CEBPB	chr17:33672982-33673479	IMR90	lung:	n/a	chr17:33673292-33673303 chr17:33673367-33673378
25	CEBPB	chr17:33673144-33673435	HepG2	liver:	n/a	chr17:33673292-33673303 chr17:33673367-33673378
26	CEBPB	chr17:33698317-33698552	A549	lung:	n/a	chr17:33698439-33698450
27	CEBPB	chr17:33731395-33731702	A549	lung:	n/a	n/a
28	CEBPB	chr17:33717812-33718023	K562	blood:	n/a	chr17:33717904-33717917 chr17:33717904-33717917 chr17:33717905-33717916
29	CEBPB	chr17:33731441-33731629	K562	blood:	n/a	n/a
30	CEBPB	chr17:33717730-33718103	K562	blood:	n/a	chr17:33717904-33717917 chr17:33717904-33717917 chr17:33717905-33717916
31	CEBPB	chr17:33673196-33673420	A549	lung:	n/a	chr17:33673292-33673303 chr17:33673367-33673378
32	CEBPB	chr17:33698339-33698621	HepG2	liver:	n/a	chr17:33698439-33698450
33	CEBPB	chr17:33700361-33701097	GM12878	blood:	n/a	n/a
34	CEBPB	chr17:33673159-33673403	K562	blood:	n/a	chr17:33673292-33673303 chr17:33673367-33673378
35	CEBPB	chr17:33731382-33731714	HepG2	liver:	n/a	n/a
36	CEBPB	chr17:33700583-33700911	Hela-S3	cervix:	n/a	n/a
37	CEBPB	chr17:33701339-33701878	Hela-S3	cervix:	n/a	n/a
38	CEBPB	chr17:33731440-33731698	IMR90	lung:	n/a	n/a
39	CHD1	chr17:33700415-33700981	GM12878	blood:	n/a	n/a
40	CHD1	chr17:33701236-33701436	GM12878	blood:	n/a	n/a
41	CHD2	chr17:33700484-33700849	Hela-S3	cervix:	n/a	n/a
42	CHD2	chr17:33700473-33701031	GM12878	blood:	n/a	n/a
43	CHD2	chr17:33673643-33673649	GM12878	blood:	n/a	n/a
44	CHD2	chr17:33695044-33695652	GM12878	blood:	n/a	n/a
45	CREB1	chr17:33700509-33700895	A549	lung:	n/a	n/a
46	CREB1	chr17:33700477-33700995	GM12878	blood:	n/a	n/a
47	CREB1	chr17:33700480-33700931	A549	lung:	n/a	n/a
48	CTBP2	chr17:33672517-33673876	H1-hESC	embryonic stem cell:	n/a	n/a
49	CTBP2	chr17:33700638-33701688	H1-hESC	embryonic stem cell:	n/a	n/a
50	CTCF	chr17:33699900-33700050	NHDF-neo	bronchial:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:33701529-33701579	A549	lung:	n/a
2	chr17:33700747-33700797	Hela-S3	cervix:	n/a
3	chr17:33700747-33700797	MCF-7	breast:	n/a
4	chr17:33701321-33701371	HL-60	blood:	n/a
5	chr17:33673476-33673526	Caco-2	colon:	n/a
6	chr17:33734481-33734531	NB4	blood:	n/a
7	chr17:33701529-33701579	A549	lung:	n/a
8	chr17:33700747-33700797	Hela-S3	cervix:	n/a
9	chr17:33700747-33700797	MCF-7	breast:	n/a
10	chr17:33701321-33701371	HL-60	blood:	n/a
11	chr17:33673476-33673526	Caco-2	colon:	n/a
12	chr17:33734481-33734531	NB4	blood:	n/a
13	chr17:33700817-33700867	HCF	heart:	n/a
14	chr17:33678143-33678193	NH-A	brain:	n/a
15	chr17:33700757-33700807	HRCEpiC	kidney:	n/a
16	chr17:33701353-33701403	SAEC	small airway:	n/a
17	chr17:33672543-33672593	GM19239	blood:	n/a
18	chr17:33700513-33700563	ProgFib	skin:	n/a
19	chr17:33700747-33700797	IMR90	lung:	fetal
20	chr17:33698288-33698338	HAEpiC	amniotic membrane:	n/a
21	chr17:33701353-33701403	Hepatocyte	liver:	n/a
22	chr17:33701529-33701579	HCT-116	colon:	n/a
23	chr17:33700230-33700280	Hepatocyte	liver:	n/a
24	chr17:33673708-33673758	HCM	heart:	n/a
25	chr17:33673476-33673526	BJ	skin:	n/a
26	chr17:33700255-33700305	K562	blood:	n/a
27	chr17:33731014-33731064	RPTEC	kidney:	n/a
28	chr17:33701350-33701400	SAEC	small airway:	n/a
29	chr17:33704726-33704776	HPAEpiC	pulmonary alveolar:	n/a
30	chr17:33700745-33700795	Hepatocyte	liver:	n/a
31	chr17:33700759-33700809	PFSK-1	brain:	n/a
32	chr17:33700180-33700230	NHDF-neo	bronchial:	n/a
33	chr17:33700801-33700851	GM06990	blood:	n/a
34	chr17:33700745-33700795	HRPEpiC	eye:	n/a
35	chr17:33734764-33734814	NB4	blood:	n/a
36	chr17:33698288-33698338	AG04450	lung:	fetal
37	chr17:33673708-33673758	HMEC	breast:	n/a
38	chr17:33673036-33673086	A549	lung:	n/a
39	chr17:33700801-33700851	NHDF-neo	bronchial:	n/a
40	chr17:33701353-33701403	NB4	blood:	n/a
41	chr17:33700180-33700230	ProgFib	skin:	n/a
42	chr17:33734847-33734897	GM12878	blood:	n/a
43	chr17:33731014-33731064	AG04449	skin:	fetal
44	chr17:33700513-33700563	AG09319	gingival:	n/a
45	chr17:33734664-33734714	Jurkat	blood:	n/a
46	chr17:33734481-33734531	AG04450	lung:	fetal
47	chr17:33672921-33672971	GM12878	blood:	n/a
48	chr17:33700180-33700230	PFSK-1	brain:	n/a
49	chr17:33698288-33698338	HCPEpiC	choroid plexus:	n/a
50	chr17:33701353-33701403	HAEpiC	amniotic membrane:	n/a

No.	Distal block	Cell Line	Cell type
1	chr17:33729515..33731700-chr17:33736981..33738686,2	K562	blood:
2	chr17:33676876..33678377-chr17:33681878..33683602,2	K562	blood:
3	chr17:33700355..33701212-chr7:100026345..100027279,2	NB4	blood:
4	chr17:33691774..33694475-chr17:33701256..33703274,2	K562	blood:
5	chr17:33675973..33676543-chr19:47291156..47291826,2	NB4	blood:
6	chr17:33749302..33751373-chr17:33754505..33756544,2	K562	blood:
7	chr17:33726969..33729366-chr17:33731337..33733299,2	K562	blood:
8	chr17:33729515..33731700-chr17:33736981..33738686,2	K562	blood:
9	chr17:33749302..33751373-chr17:33754505..33756544,2	K562	blood:
10	chr17:33676876..33678377-chr17:33681878..33683602,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SLFN12-5	chr17:33700493-33700639	NONHSAT053088
2	lnc-SLFN12-3	chr17:33727897-33728219	ENSG00000267711.1
3	lnc-SLFN12-5	chr17:33690641-33690845	NONHSAT053087
4	lnc-SLFN12-2	chr17:33730856-33731392	ENSG00000267547.1
5	lnc-SLFN11-1	chr17:33704435-33704697	NONHSAT053089
6	lnc-SLFN12-3	chr17:33729955-33730025	ENSG00000267711.1
7	lnc-SLFN12-1	chr17:33733967-33734837	NONHSAT053093
8	lnc-SLFN12-1	chr17:33736621-33737247	NONHSAT053094
9	lnc-SLFN12-1	chr17:33736484-33736787	ENSG00000267745.1
10	lnc-SLFN12-6	chr17:33687038-33687390	NONHSAT053086
11	lnc-SLFN12-5	chr17:33694285-33694719	NONHSAT053088
12	lnc-SLFN12-5	chr17:33693966-33694313	NONHSAT053087
13	lnc-SLFN5-2	chr17:33671250-33671583	NONHSAT053085
14	lnc-SLFN12-1	chr17:33733703-33734610	ENSG00000267745.1
15	lnc-SLFN12-6	chr17:33689786-33690011	NONHSAT053086

Variant related genes	Relation type
ENSG00000267547	TF binding region
SLFN11	TF binding region
ENSG00000267648	TF binding region
ENSG00000267711	TF binding region
ENSG00000267102	TF binding region
ENSG00000267315	TF binding region
SLFN12	TF binding region
ENSG00000267745	TF binding region
ENSG00000267547	CpG island
SLFN11	CpG island
ENSG00000267648	CpG island
ENSG00000267711	CpG island
ENSG00000267102	CpG island
ENSG00000267315	CpG island
SLFN12	CpG island
ENSG00000267745	CpG island
ENSG00000267102	chromatin interactions
ENSG00000267547	chromatin interactions
ENSG00000267711	chromatin interactions
ENSG00000078487	chromatin interactions
ENSG00000172716	chromatin interactions
ENSG00000146834	chromatin interactions

Extended variants
information (count: 3240 )
Associated
traits (count: 116 )

Variant overlapped rSNPs/rCNVs (count:3240 , 50 per page) page: 1 2 3 4 5 6 7 ... 65

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4074590	chr17:33671466-33671467	Bivalent Enhancer Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs565743420	chr17:33671539-33671540	Bivalent Enhancer Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
3	rs541481633	chr17:33671585-33671586	Bivalent Enhancer Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs377294395	chr17:33671600-33671601	Bivalent Enhancer Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs571750405	chr17:33671617-33671618	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs537129648	chr17:33671641-33671642	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs557556269	chr17:33671654-33671655	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs536720879	chr17:33671694-33671695	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs117076037	chr17:33671714-33671715	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs4074591	chr17:33671740-33671741	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs553658033	chr17:33671786-33671787	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs184825735	chr17:33671812-33671813	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs573238703	chr17:33671824-33671825	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs189206027	chr17:33671834-33671835	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs545029848	chr17:33671848-33671849	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs192012408	chr17:33671887-33671888	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs575325257	chr17:33671917-33671918	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs543943373	chr17:33671973-33671974	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs560764490	chr17:33672012-33672013	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs546867934	chr17:33672013-33672014	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs529796071	chr17:33672020-33672021	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs148687584	chr17:33672045-33672046	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs373139340	chr17:33672060-33672061	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs539359099	chr17:33672084-33672085	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs4073837	chr17:33672085-33672086	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs115023750	chr17:33672289-33672290	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs3902986	chr17:33672296-33672297	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs571524058	chr17:33672302-33672303	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs531053897	chr17:33672324-33672325	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs184861304	chr17:33672341-33672342	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs189658498	chr17:33672408-33672409	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs142244005	chr17:33672482-33672483	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs146719012	chr17:33672544-33672545	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs372969838	chr17:33672586-33672587	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs12938381	chr17:33672632-33672633	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs567188664	chr17:33672642-33672643	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs538940979	chr17:33672656-33672657	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs558544710	chr17:33672705-33672706	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs11080339	chr17:33672706-33672707	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs544304345	chr17:33672708-33672709	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs35716910	chr17:33672724-33672725	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs386796745	chr17:33672725-33672726	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs11080341	chr17:33672726-33672727	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs540075036	chr17:33672727-33672728	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs35062697	chr17:33672728-33672729	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs559898380	chr17:33672809-33672810	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs11080342	chr17:33672839-33672840	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs545747296	chr17:33672853-33672854	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs77481235	chr17:33672875-33672876	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs77507305	chr17:33672876-33672877	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:116)

Disease	PMID	Source
Melanoma	18172304	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Ewing''s sarcoma	21437220	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21781307	CNVD
Colorectal cancer	21645411	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Medulloblastoma	21979893	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	17603634	CNVD
T-cell lymphomas	19863542	CNVD
Cancer	16751803	CNVD
Chordoma	21602918	CNVD
Neurofibromatosis	20686819	CNVD
Peripheral nerve sheath tumors	20686819	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	17897457	CNVD
Neuroblastoma	17327916	CNVD
Breast cancer	21264507	CNVD
Endometrial cancer	22040021	CNVD
Neuroblastoma	21484798	CNVD
Breast cancer	22028636	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute myeloid leukemia	20724749	CNVD
Breast cancer	21858162	CNVD
Breast cancer	16397240	CNVD
Myxofibrosarcoma	16751306	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17157792	CNVD
Bladder cancer	19088036	CNVD
Gastric cancer	17167181	CNVD
Breast cancer	19287154	CNVD
Leukemia	20874852	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	17533364	CNVD
Human rectal carcinomas	16397240	CNVD
Meningioma	19431122	CNVD
Neurocytoma	17123091	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Lung cancer	21911935	CNVD
Breast cancer	22048815	CNVD
Cervical cancer	21062161	CNVD
Colorectal cancer	22860045	CNVD
Ductal carcinoma	18381933	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16417655	CNVD
Renal cysts	20603712	CNVD
Epilepsy	21858020	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Autism	20587423	CNVD
Renal cysts	20587423	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Mayer-Rokitansky-Kuster-Hauser syndrome	19889212	CNVD
Endometrial cancer	23636398	CNVD
Urothelial cell carcinoma	18451213	CNVD
Gastric cancer	24379144	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16785998	CNVD
Breast cancer	17850661	CNVD
Primary lung adenocarcinoma	16799635	CNVD
HIV/AIDS	18848619	CNVD
Rheumatoid arthritis	19220326	CNVD
Rheumatoid arthritis	18848619	CNVD
Systemic lupus erythematosus	19220326	CNVD
Systemic lupus erythematosus	18848619	CNVD
Type 1 diabetes	19220326	CNVD
HIV/AIDS	17330138	CNVD
Basal cell lymphoma	17053054	CNVD
Autism	19955444	CNVD
Schizophrenia	19955444	CNVD
Acute monocytic leukemia	16498392	CNVD
Breast cancer	20409316	CNVD
Myelodysplastic syndrome	18663149	CNVD
Breast cancer	17457667	CNVD
Breast cancer	16951389	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Lung cancer	19153074	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Breast cancer	20932292	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Lung cancer	18438408	CNVD
Recurrent pregnancy loss	19789632	CNVD
Breast cancer	21364760	CNVD
Breast cancer	22522925	CNVD
small cell lung cancer	20016488	CNVD
Pancreatic cancer	17952125	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:2074 , 50 per page) page: 1 2 3 4 5 6 7 ... 42

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:33668000-33672400	Enhancers	Primary monocytes fromperipheralblood	blood
2	chr17:33669200-33672200	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
3	chr17:33669200-33672400	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
4	chr17:33669200-33672400	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
5	chr17:33669400-33672200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
6	chr17:33669600-33672200	Weak transcription	Primary T helper cells fromperipheralblood	blood
7	chr17:33669800-33672200	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
8	chr17:33669800-33672400	Weak transcription	Dnd41	blood
9	chr17:33670000-33672200	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
10	chr17:33670000-33672400	Weak transcription	Primary T helper naive cells from peripheral blood	blood
11	chr17:33670000-33672600	Weak transcription	Primary B cells from peripheral blood	blood
12	chr17:33670000-33672600	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
13	chr17:33670200-33671800	Weak transcription	Primary T killer memory cells from peripheral blood	blood
14	chr17:33670400-33671600	Weak transcription	Primary T helper cells PMA-I stimulated	--
15	chr17:33670600-33672200	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
16	chr17:33671200-33671600	ZNF genes & repeats	Primary B cells from cord blood	blood
17	chr17:33671200-33671600	Bivalent Enhancer	Left Ventricle	heart
18	chr17:33671200-33671800	Enhancers	Spleen	Spleen
19	chr17:33671200-33672600	Enhancers	Primary T cells fromperipheralblood	blood
20	chr17:33671400-33671600	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
21	chr17:33671400-33671600	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
22	chr17:33671400-33671600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
23	chr17:33671400-33672400	Weak transcription	Gastric	stomach
24	chr17:33671600-33671800	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
25	chr17:33671600-33672000	Enhancers	Monocytes-CD14+_RO01746	blood
26	chr17:33671600-33672400	Weak transcription	Primary B cells from cord blood	blood
27	chr17:33671600-33672400	Enhancers	Primary T helper cells PMA-I stimulated	--
28	chr17:33671800-33672200	Weak transcription	Spleen	Spleen
29	chr17:33671800-33672600	Enhancers	Primary T killer memory cells from peripheral blood	blood
30	chr17:33672000-33674200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
31	chr17:33672200-33672400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
32	chr17:33672200-33672400	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
33	chr17:33672200-33672400	Enhancers	Primary neutrophils fromperipheralblood	blood
34	chr17:33672200-33672400	Enhancers	Primary hematopoietic stem cells short term culture	blood
35	chr17:33672200-33672400	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
36	chr17:33672200-33672400	Enhancers	Adipose Nuclei	Adipose
37	chr17:33672200-33672400	Bivalent Enhancer	Right Ventricle	heart
38	chr17:33672200-33672600	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
39	chr17:33672200-33672600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
40	chr17:33672200-33672600	Enhancers	Primary T helper cells fromperipheralblood	blood
41	chr17:33672200-33672600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
42	chr17:33672200-33672600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
43	chr17:33672200-33672800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
44	chr17:33672200-33672800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
45	chr17:33672200-33672800	Bivalent Enhancer	Fetal Thymus	thymus
46	chr17:33672200-33673000	Enhancers	Spleen	Spleen
47	chr17:33672200-33674200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
48	chr17:33672400-33672600	Bivalent/Poised TSS	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr17:33672400-33672600	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
50	chr17:33672400-33672600	Flanking Active TSS	Primary T cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links